Bo Wen

机构：IBM (United States), Nanjing Normal University, Anhui Medical University, Lustgarten Foundation, IBM Research - Thomas J. Watson Research Center, Second Affiliated Hospital of Anhui Medical University · ORCID：0000-0002-2017-1822

发表论文 22 篇 · 总被引 181 次 · h-index 8

代表论文

• Heterogeneous Integration Technology Demonstrations for Future Healthcare, IoT, and AI Computing Solutions (2018 · 被引 56)
• Using Large Language Models to Understand Suicidality in a Social Media–Based Taxonomy of Mental Health Disorders: Linguistic Analysis of Reddit Posts (2024 · JMIR Mental Health · 被引 28)
• Health Guardian Platform: A technology stack to accelerate discovery in Digital Health research (2022 · 被引 17)
• Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling (2022 · Drug Metabolism and Disposition · 被引 15)
• The Effects of Polyphenols on Doxorubicin‐Induced Nephrotoxicity by Modulating Inflammatory Cytokines, Apoptosis, Oxidative Stress, and Oxidative DNA Damage (2025 · Phytotherapy Research · 被引 14)
• A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937 (2023 · Pharmacology Research & Perspectives · 被引 11)